Brain, Vol. 115, No. 2, 399-423, 1992
© 1992 Oxford University Press
research-article |
THE CLINICAL AND EPIDEMIOLOGICAL PROFILE OF LYME NEUROBORRELIOSIS IN DENMARK 19851990
A PROSPECTIVE STUDY OF 187 PATIENTS WITH BORRELIA BURGDORFERI SPECIFIC INTRATHECAL ANTIBODY PRODUCTIONM
Borrelia Laboratory, Department of Infection-Immunology, Statens Seruminstitut Copenhagen, Denmark
Correspondence to:
Correspondence to: Klaus Hansen, Borrelia Laboratory, Department of Infection-Immunology, Statens Seruminstitut, Aruilerivej 5, DK-2300 Copenhagen S, Denmark
This prospective study reports the clinical and epidemiological features of 187 consecutive patients with neuroborreliosis recognized in Denmark over the 6-yr period, 19851990 Only patients with intrathecal Borrelia burgdorferi specific antibody synthesis were included. In 1990 regional incidences varied between 5.7 and 24.1 per million Ninety-four percent of the patients had early (second stage) neuroborreliosis. The most common manifestation was a painful lymphocytic meningoradiculitis (Bannwarth's syndrome) either with paresis (61%) or as a radicular pain syndrome only (25%). Central nervous system (CNS) involvement in early neuroborreliosis was rare; 4% had signs of myelitis and only one patient had acute encaphalitis. Children showed a different course of the disease. Six percent of the patients suffered a chronic course with a disease duration between 6 mths and 6 yrs either as chronic lymphocytic meningitis (1.6%) or as third stage chronic encephalomyelitis (4 3%). Meningeal signs were rare despite pronounced inflammatory cerebrospinal fluid (CSF) changes (median cell count 160/µ1 median protein concentration 1. 13g/1). High dose i.v penicillin G was adminustered to 91% of the patients. Based on the clinical outcome and normalization of CSF no treatment failures were recognized. The final morbidity after a median follow-up of 33 mths was low; disabling sequelae were reported in nine patients, mainly those with previous CNS involvement. We conclude that neuroborrehosis is a common and characteristic neurological disorder. The diagnsis should be based on the demonstration of inflammatory CSF changes and B. burgdorferi specific intrathecal antibody production.
Received November 7, 1991. Accepted January 10, 1992.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
O. Brorson, S.-H. Brorson, J. Scythes, J. MacAllister, A. Wier, and L. Margulis Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic Tigecycline PNAS, November 3, 2009; 106(44): 18656 - 18661. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Lanska, F . Blanc, B. Jaulhac, M. Fleury, J. de Seze, S.J. de Martino, G. Blaison, Y. Hansmann, D. Christmann, and C. Tranchant RELEVANCE OF THE ANTIBODY INDEX TO DIAGNOSE LYME NEUROBORRELIOSIS AMONG SEROPOSITIVE PATIENTS Neurology, July 8, 2008; 71(2): 150 - 151. [Full Text] [PDF] |
||||
![]() |
F. Blanc, B. Jaulhac, M. Fleury, J. de Seze, S. J. de Martino, V. Remy, G. Blaison, Y. Hansmann, D. Christmann, and C. Tranchant Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients Neurology, September 4, 2007; 69(10): 953 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Halperin, E. D. Shapiro, E. Logigian, A. L. Belman, L. Dotevall, G. P. Wormser, L. Krupp, G. Gronseth, and C. T. Bever Jr Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology, July 3, 2007; 69(1): 91 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Logina, A Krumina, G Karelis, L Elsone, L Viksna, B Rozentale, and M Donaghy Clinical features of double infection with tick-borne encephalitis and Lyme borreliosis transmitted by tick bite J. Neurol. Neurosurg. Psychiatry, December 1, 2006; 77(12): 1350 - 1353. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lakos, E. Ferenczi, S. Komoly, and M. Granstrom Different B-cell populations are responsible for the peripheral and intrathecal antibody production in neuroborreliosis Int. Immunol., December 1, 2005; 17(12): 1631 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Dinser, M C Jendro, S Schnarr, and H Zeidler Antibiotic treatment of Lyme borreliosis: what is the evidence? Ann Rheum Dis, April 1, 2005; 64(4): 519 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Morgen, R. Martin, R.D. Stone;, J. Grafman, N. Kadom, H.F. McFarland, and A. Marques FLAIR and magnetization transfer imaging of patients with post-treatment Lyme disease syndrome Neurology, December 11, 2001; 57(11): 1980 - 1985. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Rothermel, T. R. Hedges III, and A. C. Steere Optic Neuropathy in Children With Lyme Disease Pediatrics, August 1, 2001; 108(2): 477 - 481. [Abstract] [Full Text] |
||||
![]() |
M. Wilke, H. Eiffert, H.-J. Christen, and F. Hanefeld Primarily chronic and cerebrovascular course of Lyme neuroborreliosis: case reports and literature review Arch. Dis. Child., July 1, 2000; 83(1): 67 - 71. [Abstract] [Full Text] |
||||
![]() |
G. Wang, A. P. van Dam, I. Schwartz, and J. Dankert Molecular Typing of Borrelia burgdorferi Sensu Lato: Taxonomic, Epidemiological, and Clinical Implications Clin. Microbiol. Rev., October 1, 1999; 12(4): 633 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Faul, R. L. Doyle, P. N. Kao, and S. J. Ruoss Tick-Borne Pulmonary Disease: Update on Diagnosis and Management Chest, July 1, 1999; 116(1): 222 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Mathiesen, M. Christiansen, K. Hansen, A. Holm, E. Åsbrink, and M. Theisen Peptide-Based OspC Enzyme-Linked Immunosorbent Assay for Serodiagnosis of Lyme Borreliosis J. Clin. Microbiol., December 1, 1998; 36(12): 3474 - 3479. [Abstract] [Full Text] |
||||
![]() |
E. D. Shapiro and M. A. Gerber Lyme Disease and Facial Nerve Palsy: More Questions Than Answers Arch Pediatr Adolesc Med, December 1, 1997; 151(12): 1183 - 1184. [Abstract] [PDF] |
||||
![]() |
K. Stefansson and E.T. Hedley-Whyte Case 8-1996- A 28-year-old woman with the rapid development of a major personality change and global aphasia N. Engl. J. Med., March 14, 1996; 334(11): 715 - 721. [Full Text] [PDF] |
||||











